After promising to search North America for the perfect home for its next headquarters, Amazon has narrowed its list to 20 cities 19 of which are in the United States. The one exception? Toronto.
An outlier on Amazon’s list, Toronto has earned the attention of the technology world due to its diverse population, talent pool and welcome stance on immigration.
“It’s got this incredible aspiration for inclusivity,” Dan Doctoroff, CEO of Sidewalk Labs, the urban innovation arm of Google’s parent company which is developing a Toronto neighborhood, said at an event Wednesday. “If Amazon sees what we see here, it won’t even be a close call.”
Toronto is the fourth largest city by population in North America, with 2.8 million people. Its percentage of foreign-born residents in the region 39.7% exceeds every other city on Amazon’s list. Its population has grown by more than 400,000 people in the last five years.
Toronto’s appeal to the tech sector, which relies on foreign workers, has grown amid diverging stances on immigration from the U.S. and Canadian governments. Last year, Canada launched a program to process work permits and visa applications for skilled workers within two weeks.
Top 10 Canadian Stocks To Buy For 2019: Wells Fargo & Company(WFC)
- [By Virendra Singh Chauhan]
Banking, as a whole, is another sector which will benefit from a higher interest rate scenario. It is here that Berkshire will benefit from its large investments in publicly listed financial institutions. As of Sept 30, 2016, Berkshire’s investments in public financial institutions, at $42 Billion, accounted for 33% of the total holdings in public listed companies. The stocks of most large financial institutions have rallied since the election results were declared. Wells Fargo (NYSE:WFC), one of Berkshire’s largest holding is up nearly 26% since the election results were declared while American Express (NYSE:AXP), the second largest financial holding in the Berkshire portfolio is up nearly 12% in the similar time frame.
- [By Chris Lange]
Wells Fargo & Co. (NYSE: WFC) short interest shrank to 31.68 million shares from the previous reading of 35.77 million. Shares were trading at $52.10, within a 52-week range of $49.27 to $66.31.
- [By Zacks]
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
J P Morgan Chase & Co (NYSE: JPM): Free Stock Analysis Report
Comerica Incorporated (NYSE: CMA): Free Stock Analysis Report
Wells Fargo & Company (NYSE: WFC): Free Stock Analysis Report
Citigroup Inc. (NYSE: C): Free Stock Analysis Report
Wintrust Financial Corporation (NASDAQ: WTFC): Free Stock Analysis Report
Synovus Financial Corp. (NYSE: SNV): Free Stock Analysis Report
State Bank Financial Corporation. (NASDAQ: STBZ): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
- [By Ben Levisohn]
Bank stocks have rallied since Donald Trump’s election victory–even Wells Fargo (WFC), which had been hit hard by its cross selling scandal. It’s not hard to see why: Higher rates and better economic growth should be good news for ones that have been in the penalty box. And yes, Wells Fargo is still in the penalty box, say Instinet’s Bill Carcache and Yuman Lui, but that shouldn’t stop the bank from outperforming. They explain why:
Agence France-Presse/Getty Images
Wells Fargo. The company remains in the penalty box near term (e.g., possible legal accruals add to 4Q16 risk), but we view Wells Fargos reputational risk as manageable and expect the rollout of new retail banking sales incentives and the redeployment of its ~$224bn of excess liquidity (held at the Fed as of 3Q16) into higher-yielding loans to serve as positive catalysts later in the year. By our math, each $5bn redeployed into 5-year USTs yielding ~2% would drive incremental EPS of $0.01, with the upside from redeploying into higher-yielding loans even more meaningful.
Shares of Wells Fargo have gained 1.1% to $54.84 at 2:22 p.m. today, while the SPDR S&P Bank ETF (KBE) has risen 0.8% to $43.73.
Top 10 Canadian Stocks To Buy For 2019: Transcananda Pipelines Ltd.(TRP)
- [By Ben Levisohn]
In a number of articles recently, following the US recent revival and potential approval of the previously blocked Keystone XL pipeline, a number of estimates have been provided suggesting a pending boom for the US steel industry is on the horizon (and US steel stocks have reacted in kind). In fact, this optimism, we believe, peaked today when a report from one of our competitors was published claiming that, the keystone XL pipeline could increase line pipe demand by 14.7% for 2 years. The problem here, we believe, rests with the facts that: (a) TransCanada (TRP) has already taken, and paid for, the steel to build the Keystone XL pipeline (the steel currently sits in storage facilities in both Regina, Canada and Arkansas, United States), (b) neither US Steel (X; SELL), AK Steel, Steel Dynamics, or Nucor have the ability to make the specialized steel required for the miles of pipe associated with this project, to include both the thickness and pressure requirements, according to this article from Reuters, and (c) assuming some of the pipe does need replacement, this would likely come from international steel makers who are capable of producing the specialized steel (again, as highlighted in this Reuters article).
- [By WWW.KIPLINGER.COM]
Energy stocks were driven by a hefty dose of M&A during the third quarter. And that will drive returns for TransCanada Corporation (TRP) during the next one.
- [By Dustin Parrett]
TransCanada Corp. (NYSE: TRP) just achieved a perfect Money Morning stock VQScore, making it a profit powder keg waiting to ignite…
TransCanada is a Canadian oil and gas pipeline company, most famous for its development of the Keystone XL pipeline connecting Canadian oil fields to major hubs in the United States.
Top 10 Canadian Stocks To Buy For 2019: Valeant Pharmaceuticals International Inc(VRX)
- [By ]
Sometimes it’s better to raise funds when you can vs. when you have to. Look no farther than Valeant Pharmaceuticals (VRX) , which is in a massive hole of debt and trades below $20 per share. It sure would have been nice to raise capital in a secondary offering with the stock over $200 per share for six months throughout 2015.
- [By Paul Ausick]
Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 2% Friday to post a new 52-week low of $9.44 after closing Thursday at $9.63. The stock’s 52-week high is $38.50. Volume of nearly 15 million shares was about 25% below the daily average of around 19.5 million. The stock is on track to post a gain of around 0.5% for the day following an offer from Fresenius SE to acquire Akorn. Barron’s suggests that investors must believe there’s a buyer for anything, so why not Valeant?
- [By Sean Williams]
Shares of Valeant Pharmaceuticals (NYSE:VRX), an embattled drug developer whose primary method of growth over the past couple of years has been via acquisitions and price hikes on its therapies, surged as much as 15% on Thursday for their third consecutive day of strong gains. The stock was up a more modest 9% as of the closing bell.
- [By Ashley Moore]
This next company to short continues to make headlines for its purportedly illegal business practices…
Stocks to Short No. 2: Valeant Pharmaceuticals International Inc. (NYSE: VRX)
Valeant Pharmaceuticals International Inc. (NYSE: VRX) is known for its questionable business practices. The company is notorious for buying smaller pharmaceutical companies (financed with debt), firing the staff of the newly acquired company, and dramatically raising prices of the new drugs at its disposal.
- [By WWW.KIPLINGER.COM]
Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).
Top 10 Canadian Stocks To Buy For 2019: Prestige Brand Holdings Inc.(PBH)
- [By Ben Levisohn]
Castor believes the cash has disappeared into working capital, which has grown from 23% to more than 50% since 2008. Comparable company PrestigeBrand (PBH) uses 11%; Unilever(UL) and Colgate-Palmolive(CL) far less.
Top 10 Canadian Stocks To Buy For 2019: China Metro-Rural Holdings Limited(CNR)
- [By Max Byerly]
Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.
Top 10 Canadian Stocks To Buy For 2019: Plains All American Pipeline L.P.(PAA)
- [By Dustin Parrett]
We think Plains All American Pipeline L.P. (NYSE: PAA) is one of the best oil stocks to buy this year. In fact, we see a scenario where PAA stock could jump 20% in 2017.
- [By Dustin Parrett]
Plains All American Pipeline (NYSE: PAA) controls 4 million barrels of crude oil and natural gas a day.
And with higher oil prices and fewer restrictions leading to more drilling, PAA’s pipelines will be in demand in 2017.
- [By Matthew DiLallo]
One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.
Top 10 Canadian Stocks To Buy For 2019: Encana Corporation(ECA)
- [By WWW.THESTREET.COM]
In the Lightning Round, Cramer was bullish on Vodafone Group (VOD) , Schlumberger (SLB) , Encana (ECA) , Arconic (ARNC) and AdvanSix (ASIX) .
Cramer was bearish on U.S. Silica Holdings (SLCA) .
- [By Money Morning News Team]
Canada-based Encana Corp. (NYSE: ECA) was the eighth top oil company stock in 2016, with a 131% gain over the year. ECA and its subsidiaries focus on developing, exploring, producing, and marketing natural gas, liquefied natural gas, and oil in North America.
- [By Paul Ausick]
Encana Corp. (NYSE: ECA) is rated Buy with an unchanged price target of $16. The EPS estimate for 2017 was lowered from $0.42 to $0.34, and the 2018 estimate was also lowered, from $1.47 to $1.28. The shares ended the weekat $11.44, in a 52-week range of $4.90 to $13.85. The consensus 12-month price target is $14.95.
Top 10 Canadian Stocks To Buy For 2019: Rhino Resource Partners LP(RNO)
- [By Alexis Xydias]
Investors are regaining confidence, squeezing pessimists who say the economy remains sluggish outside of Germany and point to record-low trading volume as a lack of conviction in the Euro Stoxxs 61 percent rally of the past two years. Besides gains in stocks from Banco Bilbao Vizcaya Argentaria SA to Renault SA (RNO), yields on Spanish and Italian bonds have declined to a two-year low compared with German bunds and the euro has strengthened 4.6 percent to $1.35 in the past six months.
Top 10 Canadian Stocks To Buy For 2019: Nu Skin Enterprises Inc.(NUS)
- [By Craig Jones]
Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.
- [By Ben Levisohn]
Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:
“Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…
Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.
Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.
Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.
- [By ]
Nu Skin Enterprises (NYSE: NUS) is benefiting from two key trends: its strong presence in Asia where it books 79% of its revenue and leading brand awareness with millennials. The company has increased its dividend every year since 2001, now paying a 2% yield, and maintains a share repurchase program that returns excess cash to shareholders.
- [By Scott Rubin]
Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.
Top 10 Canadian Stocks To Buy For 2019: Talisman Energy Inc.(TLM)
- [By Jayson Derrick]
On the other hand, the analysts are Underweight on Eni SpA (ADR) (NYSE: E), Repsol Oil & Gas Canada Inc (USA) (NYSE: TLM) and OMV AG given their asset bases, which offer an inferior risk to reward profile and limited differentiation in cost reductions.